Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             186 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A bispecific antibody that simultaneously recognises the V2- and V3-glycan epitopes of the HIV-1 envelope glycoprotein Davis-Gardner, M.
S3 p. 56
 artikel
2 A delicate balance between the number of RBEIII and NF-κB motifs impacts latency kinetics in HIV-1 Ranga, U.
S3 p. 10
 artikel
3 A mechanistic modelling platform for HIV cure drug development Cao, Y.
S3 p. 45
 artikel
4 A modified TZM-bl assay (MoCo-TZA) documents replication-competent HIV in circulating monocytes despite 2 years of antiretroviral therapy initiated early during acute infection Mitchell, B.
S3 p. 35-36
 artikel
5 Analytical treatment interruption and rearrangement of HIV-1 drug resistance mutations in peripheral reservoir Bruzzesi, E.
S3 p. 43-44
 artikel
6 A novel, ultra-sensitive technology for quantifying the HIV unintegrated linear DNA responsible for pre-integrative latency Dutrieux, J.
S3 p. 9-10
 artikel
7 A novel, ultra-sensitive technology for quantifying the HIV unintegrated linear DNA responsible for pre-integrative latency Dutrieux, J.
S3 p. 10
 artikel
8 Antagonism of PPARγ for Th17 mucosal immunity restoration and HIV reservoir purging Planas, D.
S3 p. 53-54
 artikel
9 An unbiased platform to identify regulators of HIV latency in infected primary human CD4 T Cells Rathore, U.
S3 p. 14
 artikel
10 A quantitative single cell, single molecule RNA-FISH+IF and single cell RNA-seq analysis reveals stochasticity of reactivation of latent provirus Kalpana, G.
S3 p. 1
 artikel
11 Automated high-throughput quantification of persistent HIV-1 plasma viremia in individuals on ART Jacobs, J.
S3 p. 24-25
 artikel
12 Awareness of HIV cure-directed research among HIV clinic patients in Philadelphia Freshwater, W.
S3 p. 41
 artikel
13 Barcoded HIV reveals effects of PKC modulation on viral reservoir Zack, J.
S3 p. 20
 artikel
14 Barcoded viruses facilitate tracking changes to the composition of the rebound-competent reservoir Keele, B.
S3 p. 16
 artikel
15 Baseline inducible HIV P24 is associated with viral control during interferon-α monotherapy with ART interruption Montaner, L.J.
S3 p. 32-33
 artikel
16 B cell depletion alone or in combination with IL-15 or PD-1 blockade facilitates enhanced control of virus replication in SIV-infected rhesus macaques Picker, L.J.
S3 p. 51
 artikel
17 B cells mediate R5-Tropic HIV infection of CCR5neg naive CD4 T cells Gerberick, A.
S3 p. 36
 artikel
18 BCL-2 antagonism sensitises CTL-resistant HIV reservoirs to elimination ex vivo Jones, R.B.
S3 p. 34
 artikel
19 Behind the scenes: clinical and rapid autopsy staff members’ experiences and perceptions of HIV reservoir research at the end of life Perry, K.
S3 p. 42
 artikel
20 α4β7-blockade delays viral rebound in SHIV infected macaques treated with a combination of HIV bNAbs Martinelli, E.
S3 p. 48
 artikel
21 Block and kill: a new approach to a prevent HIV reactivation, reduce immnue activation, induce apoptosis of infected cells Garzino Demo, A.
S3 p. 55
 artikel
22 Blocking TIM-3 reinvigorates exhausted CD8 T cells with no impact on NK cell function in ART-treated HIV-infected patients Gutiérrez, C.
S3 p. 51-52
 artikel
23 Broad-spectrum gRNAs abolish HIV-1 LTR-mediated transcription in cells that receive CRISPR/Cas9 therapy Wigdahl, B.
S3 p. 54
 artikel
24 CD4 T cells from patients with chronic myeloid leukemia are resistant to HIV-1 proviral integration and transcription after prolonged withdrawal of treatment with tyrosine kinase inhibitors Vigón, Lorena
S3 p. 53
 artikel
25 Cell-associated provirus size decreases in the xenografted CD4 T cells from chronically infected natural host in a novel simianized mice model Yuan, Z.
S3 p. 18-19
 artikel
26 Cell proliferation contributes to the increase of genetically intact HIV over time Palmer, S.
S3 p. 9
 artikel
27 Characterising antibody responses in ART-treated individuals Wilson, A.
S3 p. 33
 artikel
28 Characterising ‘exceptional’ control among HIV elite controllers Peluso, M.
S3 p. 31
 artikel
29 Chimeric antigen receptor T Cells and stem cells control and protect against SHIV replication in non-human primates Peterson, C.
S3 p. 16-17
 artikel
30 Cleavage and polyadenylation specific factor 6 is required for HIV latency reversal Zheng, Y.
S3 p. 11-12
 artikel
31 Cleaving HIV-1 provirus from ART-suppressed patient-derived resting CD4 T Cells using Cpf1/crRNA-array ribonucleotide protein packaged by CD4-targeting lentivirus-like particle Hu, W.
S3 p. 55-56
 artikel
32 Clones of HIV-infected cells are widely distributed in T cell subsets in blood and in anatomic tissues Maldarelli, F.
S3 p. 39-40
 artikel
33 Collaboration in community education: BEAT-HIV Community Engagement Group (CEG) and the HIV cure research education video series Montaner, L.J.
S3 p. 41-42
 artikel
34 Combination of quadruplex qPCR and next-generation sequencing for qualitative and quantitative analysis of the HIV-1 latent reservoir Gaebler, C.
S3 p. 3
 artikel
35 Combinatorial latency reversal activity of inhibitor of apoptosis antagonists with mechanistically distinct classes of HIV latency reversal agents Falcinelli, Shane D.
S3 p. 47-48
 artikel
36 Conditions for post-rebound SHIV control in autologous hematopoietic-stem cell transplantation Cardozo, F.
S3 p. 58
 artikel
37 Contribution of antigenic exposure to the persistence of HIV-infected CD4 T cells in vivo Simonetti, F.
S3 p. 23-24
 artikel
38 CRISPR/Cas9 editing of HIV-1 transcription factor binding sites on the 5’ long terminal repeats to permanently inactivate latent provirus Wigdahl, B.
S3 p. 54-55
 artikel
39 CXCR4-usage HIV-1 strains isolated from blood and cerebrospinal fluid in subjects on suppressive antiretroviral therapy Nath, A.
S3 p. 28-29
 artikel
40 Degradation of the XPB subunit of TFIIH by spironolactone reduces HIV-1 reactivation from latency Mori, L.
S3 p. 12
 artikel
41 Delay in viral rebound with TLR7 agonist, N6-LS and PGT121 in SHIV-infected macaques Hsu, D.
S3 p. 16
 artikel
42 Development of anti-PD-1 chimeric antigen receptor T cells to target a PD-1+ CD4 T cell population enriched in HIV provirus Eichholz, K.
S3 p. 58
 artikel
43 Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy Peluso, M.
S3 p. 23
 artikel
44 Distinct HIV reservoir measures correlate with defective but not intact pro-viral DNA Papasavvas, E.
S3 p. 7
 artikel
45 Diversity of the replication-competent HIV reservoir in treated patients Mammano, F.
S3 p. 26-27
 artikel
46 Donor T cell chimerism correlates with viral reservoir clearance following allogeneic stem cell transplantation in fully cART-suppressed Mauritian cynomolgus macaques Wu, Helen L.
S3 p. 19
 artikel
47 Dynamics of HIV-specific T cells on long-term ART differ by antigen recognised and by sex Stevenson, Eva M.
S3 p. 32
 artikel
48 Effect of natural killer cells on viral rebound in HIV-1-infected humanized mice Kim, J.
S3 p. 18
 artikel
49 Elimination of HIV-1/SHIV infected cells by combinations of bispecific HIV x CD3 DART® molecules Tuyishime, M.
S3 p. 17-18
 artikel
50 Enhancement of antibody-dependent cellular phagocytosis is essential to the clearance of HIV-1 reservoirs in lymphoid organs Shan, L.
S3 p. 56-57
 artikel
51 Enhancement of antiviral CD8 T-cell responses and complete remission of metastatic melanoma in an HIV-1 infected subject treated with pembrolizumab Blanch-Lombarte, O.
S3 p. 33
 artikel
52 Enhancing antiretroviral drug penetration into lymph nodes through intramuscular and subcutaneous routes of administration in BALB/c mice Dyavar, Shetty Ravi
S3 p. 45-46
 artikel
53 Epigenomic characterisation of a primary cell model of HIV latency Browne, E.
S3 p. 10-11
 artikel
54 Evaluating latency reactivation synergies between the bromodomain inhibitor iBET-151 and the SMAC mimetic AZD5582 in SIV-infected macaques on ART Okoye, A.A.
S3 p. 21
 artikel
55 Evaluation of IAP/SMAC mimetics as latency reversal agents in primary cells and cytokine induction in in vivo models predictive of cytokine release Howell, B.
S3 p. 4
 artikel
56 Exploring sequence specific silencing of latent HIV using CRISPR interference Schwarzer, R.
S3 p. 56
 artikel
57 Expression of CircRNAs in HIV-1 latently infected cells from an in vitro model Iniguez, L.
S3 p. 11
 artikel
58 Expression profiling of HIV latently-infected cells using nanostring and mass cytometry Sperber, H.
S3 p. 1
 artikel
59 Factors associated with viral control after structured treatment interruptions Jilg, N.
S3 p. 13-14
 artikel
60 From reservoirs to the real world: a framework for integrating behavioural and social sciences research into biomedical HIV cure-related research Dube, K.
S3 p. 40
 artikel
61 Genome-wide RNAi screen identifies MAPK-RPK required for HIV-1 proviral silencing in non-T cell reservoir cell-line model Takeuchi, H.
S3 p. 5
 artikel
62 Harnessing the specialised effector function of FcRγ− NK cells to control HIV-1 infection Anderko, R.
S3 p. 36
 artikel
63 HBV-related inflammation is linked to the level of genetically intact HIV proviruses Wang, X.
S3 p. 5-6
 artikel
64 High-throughput sequencing of integrated HIV-1 reveals novel proviral structures Joseph, K.
S3 p. 25-26
 artikel
65 Histone deacetylase inhibitors induce transcription of unspliced but not multiply spliced HIV-1 RNA from proviral genomes during latency reversal, affecting antigen presentation and detection by CD8+ T cells Mota, T.
S3 p. 7
 artikel
66 HIV-1 diversity considerations for clinical studies of passively transferred broadly neutralising antibodies Wagh, K.
S3 p. 55
 artikel
67 HIV-1 genomes cluster in nuclear niches of human macrophages Di Nunzio, F.
S3 p. 14-15
 artikel
68 HIV-infected cells that survive co-culture with HIV-specific CTL exhibit distinctive viral messenger RNA transcript profiles Jones, R.B.
S3 p. 26
 artikel
69 HIV-infected macrophages evade NK cell-mediated killing while driving inflammation Clayton, K.
S3 p. 35
 artikel
70 HIV integration site selection in the 3D genome: impact on viral and host gene expression Benkirane, M.
S3 p. 7-8
 artikel
71 HIV-1 in the latent reservoir is largely sensitive to circulating T cells Warren, J.
S3 p. 43
 artikel
72 HIV particles expressed in semen under INSTI-based suppressive therapy are largely myeloid cell-derived and exhibit widely diverse genotypes Johnson, J.
S3 p. 37-38
 artikel
73 HIV particles expressed in semen under INSTI-based suppressive therapy are largely myeloid cell-derived and exhibit widely diverse genotypes Johnson, J.
S3 p. 42-43
 artikel
74 HIV persistence despite reservoir decay during combinatorial immunotherapy including therapeutic conserved elements (CE) DNA vaccination, αPD-1 therapy, GS-986 TLR7-agonism, and CCR5 gene-edited CD4 T cell infusion in rhesus macaques Dross, S.
S3 p. 49-50
 artikel
75 HIV post-treatment control despite plasma viral evolution and dual infection Li, J.
S3 p. 37
 artikel
76 HIV proviruses with identical sequences arise from cell expansion and infection by a common ancestor virus Patro, S.
S3 p. 26
 artikel
77 HIV-1 replication is metabolically regulated in an ex vivo human tonsil histoculture model of infection Furler, R.
S3 p. 6
 artikel
78 HIV-1 sequence compartmentalisation and evolution in CNS and immune tissue Gonzalez-Perez, M.
S3 p. 29-30
 artikel
79 HLA-E-presented peptides as novel targets for HIV-1 therapy Brackenridge, S.
S3 p. 57-58
 artikel
80 How long is long-term? Delivery of anti-HIV antibodies using AAV vector Martinez-Navio, J.
S3 p. 49
 artikel
81 IL-17A imprints intestinal epithelial cells with the ability to promote HIV-1 dissemination/outgrowth in CD4 T cells Wiche Salinas, T.
S3 p. 20-21
 artikel
82 Impact of anti-PD-1 and anti-CTLA-4 on the HIV reservoir in vivo: AMC-095 Study Lewin, SharonR
S3 p. 38
 artikel
83 Improved killing of HIV-infected cells by a combination of three antibodies: implications for clearing persistent infection Tuyishime, M.
S3 p. 52
 artikel
84 Index
S3 p. 59-62
 artikel
85 Intact and replication-competent reservoir virus populations differ from each other and rebound plasma viruses Bar, K.
S3 p. 30
 artikel
86 Intact HIV genomes are enriched in memory T cells with short half-lives Morcilla, V.
S3 p. 5
 artikel
87 Intact proviral DNA levels decline in people with HIV on antiretroviral therapy Cyktor, J.
S3 p. 38
 artikel
88 Intact proviruses from naive and effector memory T-cells match persistent viremia Fisher, K.
S3 p. 6
 artikel
89 Intensification of ART with ABX464 decreases the total HIV reservoir and HIV transcription initiation in CD4 T cells from HIV-infected ART-suppressed individuals Moron-Lopez, S.
S3 p. 49
 artikel
90 Interactions with pathogenic bacteria induce HIV-1 latency in macrophages through altered transcription factor recruitment to the LTR Hanley, T.
S3 p. 8
 artikel
91 Intra- and inter-individual HIV diversity limits the application of the intact proviral detection assay (IPDA) Kinloch, Natalie N.
S3 p. 9
 artikel
92 In vitro demonstration of a potential role for STING agonist in HIV cure Koblansky, A.
S3 p. 45
 artikel
93 In vivo analysis of HIV from an occupational exposure to laboratory adapted HIV-IIIB with 20-year follow-up: implications for reservoir formation Lange, C.
S3 p. 27-28
 artikel
94 Isolation of monoclonal antibodies targeting HLA-E/HIV-1 and SIV peptide complexes Li, D.
S3 p. 52
 artikel
95 μ-Lat: a high-throughput humanised mouse model of latent HIV infection Sperber, H.
S3 p. 19
 artikel
96 Live track of HIV genome in the nuclear space Di Nunzio, F.
S3 p. 4-5
 artikel
97 Location, abundance and persistence of CAR/CXCR5 transduced T cells within lymphoid tissues of SIV-infected rhesus macaques Abdelaal, H.
S3 p. 47
 artikel
98 Longitudinal sequencing reveals multiphasic decay of HIV reservoir Cannon, L.
S3 p. 30
 artikel
99 Long-term persistence of HIV-infected cell clones in early treated children Bale, M.
S3 p. 28
 artikel
100 Low-level persistent/latent HIV-1 infection of macrophages corresponds to decreased NF-kB activity Hanley, T.
S3 p. 8-9
 artikel
101 Low viral reservoir treated individuals show unusual HIV latency distribution Gálvez, C.
S3 p. 24
 artikel
102 Maraviroc reactivates HIV with a potency similar to that of other latency reversing drugs without inducing toxicity in CD8 T cells Moreno, S.
S3 p. 52-53
 artikel
103 Marked variation in the susceptibility of HIV-1 to type 1 interferon inhibition during early, late and rebound infection Gondim, M.
S3 p. 29
 artikel
104 Marker of gut damage REG3α and microbial translocation are associated with integrated HIV DNA in CD4 T cells during early HIV infection Isnard, S.
S3 p. 34
 artikel
105 Modulated production of endogenous anti-HIV broadly neutralising antibodies Gao, Y.
S3 p. 53
 artikel
106 Multiplexed RNA flow cytometric FISH allows single-cell viral transcriptional profiling and phenotypic characterisation of translation-incompetent HIV reservoirs Kaufmann, D.
S3 p. 24
 artikel
107 Multispecific anti-HIV duoCAR-T cell therapy mediates robust HIV suppression and elimination of HIV-infected cells in humanised mice Anthony-Gonda, K.
S3 p. 47
 artikel
108 Next generation sequencing in a direct infection model reveals important parallels to in vivo reservoir dynamics O’Doherty, U.
S3 p. 21
 artikel
109 Novel SHIVs encoding transmitted/founder Envs for latency and cure research Bauer, A.
S3 p. 22
 artikel
110 O1 Added value of HIV-1 DNA load analysis in routine patient monitoring Mortier, Virginie
S3 p. 1
 artikel
111 O8 Cell-associated HIV-1 unspliced RNA level predicts both time to virological suppression and duration of post-treatment virological control in patients treated with temporary early ART Pasternak, Alexander
S3 p. 3
 artikel
112 O5 CRISPR/Cas9-derived activation systems as new tools for induction of latent human immunodeficiency virus (HIV) Bialek, JuliaK
S3 p. 2
 artikel
113 O2 Cross-validation of HIV DNA assays to quantify different HIV-1 subtypes by ddPCR Rutsaert, S.
S3 p. 1
 artikel
114 O7 Does viral suppressive capacity in cART-treated HIV-infected patients correlate with disease parameters, viral reservoir measures or cytotoxic T cell phenotype? Pannus, P.
S3 p. 3
 artikel
115 O4 Early start of antiretroviral therapy (ART) during primary HIV infection (PHI) is associated with faster optimal immunological recovery: results of Italian Network of ACuTe HIV InfectiON (INACTION) retrospective study Muscatello, A.
S3 p. 1-2
 artikel
116 O3 Heme-arginate as a latency-reversing agent for HIV-1 cure Madlenakova, Michaela
S3 p. 1
 artikel
117 O2 Identification of a new factor involved in DNA methylation-mediated repression of latent HIV-1 Bouchat, S.
S3 p. 1
 artikel
118 O9 Immunovirological outcome of HIV-infected children living in a resource-limited setting of South Africa Beghin, J.-C.
S3 p. 3
 artikel
119 O7 Implication of DNA methylation in HIV-1 post-integration latency. Verdikt, Roxane
S3 p. 3
 artikel
120 O8 Integration site detection in 10 chronically infected patients Cole, Basiel
S3 p. 3
 artikel
121 Optimisation of Smac mimetics as HIV-1 latency reversing agents Pache, L.
S3 p. 37
 artikel
122 O3 Quantifying and characterising the HIV reservoir in virally suppressed patients Pannus, Pieter
S3 p. 1
 artikel
123 O6 Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir Darcis, Gilles
S3 p. 2
 artikel
124 Origin of rebound virus in chronically SIV-infected monkeys following treatment discontinuation Barouch, D.
S3 p. 20
 artikel
125 O6 Single doses as low as 0.5 mg of the novel NRTTI MK-8591 suppress HIV for at least 7 days De Lepeleire, Inge
S3 p. 2
 artikel
126 O4 Spatial distribution of HIV in antiretroviral-treated humanised mice Fievez, Virginie
S3 p. 1-2
 artikel
127 O5 The expression profile of host restriction factors in different cohorts of HIV-1-infected patients Van Hecke, C.
S3 p. 2
 artikel
128 O1 Towards a block-and-lock strategy: LEDGINs hamper the establishment of a reactivation competent reservoir Vansant, Gerlinde
S3 p. 1
 artikel
129 P3 An insertion of seven amino acids in the envelope cytoplasmic tail of human immunodeficiency virus type 2 (HIV-2) selected during disease progression enhances viral replication Dufrasne, FrançoisE
S3 p. 4
 artikel
130 P2 A single monotherapy dose of MK-8591, a novel NRTI, suppresses HIV for 10 days Robberechts, Martine
S3 p. 4
 artikel
131 P2 Clinical evaluation of the next-generation sequencing (NGS) for detection of drug-resistance mutations in HIV-1 Dessilly, G.
S3 p. 4
 artikel
132 P1 Contribution of lncRNAs in the establishment of HIV latency in central memory CD4 T Cells Trypsteen, Wim
S3 p. 4
 artikel
133 PD-1 blockade boost vaccine-induced anti-HIV responses in the absence of HIV reactivation Prado, J.G.
S3 p. 50
 artikel
134 PD-1+ CD4 T cells are associated with HIV reservoir size and impaired function of T follicular helper cells in children and young adults on long-term viral control Rinaldi, S.
S3 p. 34-35
 artikel
135 P3 Early evidence of antiviral activity and safety of ABX464 in HIV treatment-naïve patients Scherrer, Didier
S3 p. 4-5
 artikel
136 Peripheral blood SIV/HIV originates from infected cells in tissues Betts, M.
S3 p. 27
 artikel
137 Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure Gálvez, C.
S3 p. 41
 artikel
138 Persistent HIV reservoir suppression by (-)-hopeaphenol, a plant-derived stilbenoid Tietjen, I.
S3 p. 44
 artikel
139 Phorbol esters isolated from Croton megalobotrys reverse HIV latency ex vivo Tietjen, I.
S3 p. 44
 artikel
140 Plasma and antibody glycomic biomarkers of time to HIV rebound and viral setpoint Abdel-Mohsen, M.
S3 p. 38-39
 artikel
141 P4 Long-term aviremia after discontinuation of antiretroviral treatment Kinloch-de Loës, Sabine
S3 p. 5
 artikel
142 Post-ATI viremia in a hyperacute subject comprises macrophage-tropic viral variants Machado, V.
S3 p. 28
 artikel
143 Post-therapy viral set-point abatement following combined antiproliferative and immune-boosting interventions: results from a randomised clinical trial Sobhie Diaz, R.
S3 p. 50
 artikel
144 P4 Preclinical evaluation of an mRNA-based therapeutic HIV vaccine candidate combining rationally selected antigenic sequences and potent adjuvant signals (HTI-TriMix) Tjok Joe, P.
S3 p. 5
 artikel
145 P1 Protein expression from unintegrated HIV-1 DNA introduces bias in primary in vitro latency models Bonczkowski, Pawel
S3 p. 4
 artikel
146 Proteasomal degradation of PML protein is a stress response to HIV-1 replication and reactivation Shytaj, I.
S3 p. 11
 artikel
147 Protein crotonylation sensitizes SMACm disruption of latent HIV by modulating the ncNF-κB signaling pathway at the step of p100 cleavage into p52 Guochun, J.
S3 p. 8
 artikel
148 Proviral landscape in children parallels adults and enables reservoir reconstruction Hasson, J.
S3 p. 25
 artikel
149 Quantifying the contribution of cellular proliferation to maintaining the HIV reservoir Hill, A.
S3 p. 2
 artikel
150 Rapid ART in blood donors with acute and recent HIV clade C infection in South Africa Murphy, E.
S3 p. 43
 artikel
151 Remodeling of the core leads HIV-1 pre-integration complex into the nucleus of human lymphocytes di Nunzio, F.
S3 p. 3
 artikel
152 Replacing daily cART with AAV-expressed eCD4-Ig Gardner, M.
S3 p. 48
 artikel
153 Resistance to the Tat inhibitor didehydro-cortistatin A is mediated by heightened basal HIV-1 transcription Mediouni, S.
S3 p. 57
 artikel
154 Restriction factor expression in HIV-1 vertically-infected children Copertino Jr, D.
S3 p. 35
 artikel
155 Sex differences in the latent reservoir of virally suppressed HIV-1 infected individuals living in Rakai, Uganda Quinn, T.C.
S3 p. 39
 artikel
156 Single cell analysis of in vivo HIV reservoir uncovers novel markers of latent cells Roan, N.
S3 p. 2
 artikel
157 Single cell analysis reveals molecular signatures of HIV latency in primary cell models Telwatte, S.
S3 p. 4
 artikel
158 Single-cell multiplexed RNA flow-FISH analysis of primary human samples reveals distinct VR reactivation profiles among LRA classes and curtailed VR transcriptional and translational reactivation patterns by HDAC inhibitors Kaufmann, D.
S3 p. 29
 artikel
159 Single-cell phenotyping of HIV-infected expanded clones in ART-suppressed individuals Dufour, C.
S3 p. 31-32
 artikel
160 Single cell RNA-seq identifies host genes that correlate with HIV-1 reservoir size Thomas, R.
S3 p. 39
 artikel
161 Single-cell TCR sequencing reveals that clonally expanded cells highly contribute to the inducible HIV reservoir during ART Gantner, P.
S3 p. 31
 artikel
162 Single-cell transcriptome of in vivo SIV-infected rhesus macaque CD4 T cells Tokarev, A.
S3 p. 22
 artikel
163 Single-cell transcriptome sequencing of latently-infected cells ex vivo using PCR-activated cell sorting (PACS) Boritz, E.
S3 p. 1-2
 artikel
164 Specificity of bivalent chemical degraders targeted to the BET proteins Turner, A.-M.
S3 p. 13
 artikel
165 Subtype and tropism can influence the establishment and inducibility of latent HIV-1 in primary CD4 T cells Sarabia, I.
S3 p. 18
 artikel
166 Targeting HIV-1-driven aberrant transcription and proliferation Ho, Y.-C.
S3 p. 44-45
 artikel
167 Targeting lncRNA SAF to induce apoptosis in HIV-1 infected macrophages Boliar, S.
S3 p. 51
 artikel
168 Targeting STAT SUMOylation to enhance NK cell cytotoxicity Macedo, A.
S3 p. 54
 artikel
169 Tat inhibition by didehydro-cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeat Li, C.
S3 p. 57
 artikel
170 Th2 cytokines are associated with higher levels of intact proviruses on ART Cyktor, J.
S3 p. 33-34
 artikel
171 The dynamics of HIV-1 quasispecies diversity circulating in the plasma RNA and cellular DNA of patients with ART Liying, M.
S3 p. 25
 artikel
172 The human IL-15 superagonist N803 does not reverse latency in ART-suppressed, SHIV-infected macaques Webb, G.
S3 p. 48-49
 artikel
173 The IciStem consortium: T-cell immunology in HIV-1 infected individuals after allogeneic stem cell transplantation Eberhard, J.
S3 p. 32
 artikel
174 The latency reversal activity of the SMAC mimetic AZD5582 in ART-suppressed SIV-infected rhesus macaques is potentiated by CD8a cell depletion Mavigner, M.
S3 p. 17
 artikel
175 Tissue-specific differences in the mechanisms that govern HIV latency in blood, liver, gut and genital tract in ART-suppressed women Moron-Lopez, S.
S3 p. 40
 artikel
176 Treatment of SHIV-infected, ART-suppressed rhesus macaques with bispecific HIVxCD3 DART® molecules Gorman, Daniel M.
S3 p. 22
 artikel
177 Tyrosine kinase inhibition: the new front in HIV cure efforts Planelles, V.
S3 p. 3
 artikel
178 Ultradeep analysis of pretherapy HIV predicts large and genetically complex reservoirs during antiretroviral therapy Huik, K.
S3 p. 27
 artikel
179 Unprimed CD8 lymphocytes promote the establishment of HIV latency in CD4 T cells Franchitti, L.
S3 p. 19-20
 artikel
180 Updates on two public databases for studies of HIV persistence; the Retrovirus Integration Database (RID) and HIV Proviral Sequence Database (PSD) Shao, W.
S3 p. 12-13
 artikel
181 Using single-cell analysis and a primary model of HIV to study latency establishment and reactivation De Armas, L.
S3 p. 12
 artikel
182 Utilising correlative PET/CT and multiscale imaging to define the dynamics of SIV-infected cells from early ART initiation to the rebound after analytic treatment interruption Hope, T.
S3 p. 17
 artikel
183 Utilising genetic barcodes to understand the role of silent integration in HIV latency Larragoite, E.
S3 p. 13
 artikel
184 Virological impact of HCV elimination with DAAs in the HIV reservoir in HIV/HCV patients Coiras, M.
S3 p. 42
 artikel
185 Visualisation of HIV reactivation from latency in primary resting memory T-cells Kizito, F.
S3 p. 14
 artikel
186 Women undergoing reproductive aging show increased reservoir sizes associated with removal of hormonal control of HIV-1 latency by oestrogen Dobrowolski, C.
S3 p. 23
 artikel
                             186 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland